assertion_id	disorder_id	disorder_name	source_file	section	section_index	name	description	category	frequency	diagnostic	context	subtype	role	presence	association	accession	age_range	background	base_model	classification	clinical_significance	consequence	data_type	de_novo_rate	definition_type	duration	effect	expressivity	features	genotype	incubation_days	incubation_years	markers	maximum_value	mean_range	minimum_value	model_format	model_id	model_software	model_type	notes	parent_of_origin_effect	penetrance	percentage	phase	platform	population	publication	repository_url	results	review_notes	sample_count	scope	sequence_length	severity	species	specificity	status	subtype_frequency	title	type	unit	scalar_fields_json	complex_fields_json	raw_json
923	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	0	Incidence, Developed Countries																												1		0.1																										cases per 100,000 population per year	"{""maximum_value"": 1, ""minimum_value"": 0.1, ""name"": ""Incidence, Developed Countries"", ""unit"": ""cases per 100,000 population per year""}"	{}	"{""evidence"": [{""explanation"": ""The incidence of invasive meningococcal disease in the Tel Aviv District falls within the range of 0.1 to 1 cases per 100,000 population per year mentioned in the statement, but it slightly exceeds the maximum value of 1 in some years."", ""reference"": ""PMID:31495596"", ""snippet"": ""In the Tel Aviv District, the incidence rates ranged from 0.4 to 1.4 cases per 100,000 population per year during 2007-2017."", ""supports"": ""PARTIAL""}, {""explanation"": ""The statement is partially supported as the incidence in developed countries is generally low but can exceed the maximum value of 1 case per 100,000 population per year in some regions."", ""reference"": ""PMID:26453240"", ""snippet"": ""Most countries had a yearly invasive NmB incidence of less than 2 per 100,000 people. Within these relatively low incidence rates (compared with common causes of invasive bacterial diseases), substantial variation was detected between countries, with a notably higher incidence in Australia, Europe, North America, and South America."", ""supports"": ""PARTIAL""}], ""maximum_value"": 1, ""minimum_value"": 0.1, ""name"": ""Incidence, Developed Countries"", ""unit"": ""cases per 100,000 population per year""}"
924	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	1	Incidence, Developing Countries																												10		1					Higher incidence due to lower vaccination rates and crowded living conditions																					cases per 100,000 population per year	"{""maximum_value"": 10, ""minimum_value"": 1, ""name"": ""Incidence, Developing Countries"", ""notes"": ""Higher incidence due to lower vaccination rates and crowded living conditions"", ""unit"": ""cases per 100,000 population per year""}"	{}	"{""evidence"": [{""explanation"": ""The incidence rate of bacterial meningitis in the Nottingham District Health Authority area is higher than the stated range of 1 to 10 cases per 100,000 population per year. However, this reference does not specifically address developing countries."", ""reference"": ""PMID:8333768"", ""snippet"": ""This 10 year retrospective study of all causes of bacterial meningitis for children resident in Nottingham District Health Authority area reports an annual incidence rate per 100,000 children aged 0-16 years of 16.0 (95% confidence interval 14.0 to 18.1)."", ""supports"": ""PARTIAL""}, {""explanation"": ""The incidence rate of Hib meningitis in Pacific island countries is significantly higher than the stated range of 1 to 10 cases per 100,000 population per year. This suggests that bacterial meningitis can have a higher incidence in certain developing regions, though it does not provide a comprehensive view across all developing countries."", ""reference"": ""PMID:18181445"", ""snippet"": ""The Hib meningitis annual incidence in three PICs was 70 to 84 per 100,000 children under five years."", ""supports"": ""PARTIAL""}, {""explanation"": ""The average annual incidences for different bacterial causes of meningitis in the African meningitis belt fall within the stated range of 1 to 10 cases per 100,000 population per year, supporting the statement partially."", ""reference"": ""PMID:31671441"", ""snippet"": ""Average annual incidences for N. meningitidis, S. pneumoniae, and H. influenzae, respectively, were 7.5, 2.5, and 0.3."", ""supports"": ""PARTIAL""}], ""maximum_value"": 10, ""minimum_value"": 1, ""name"": ""Incidence, Developing Countries"", ""notes"": ""Higher incidence due to lower vaccination rates and crowded living conditions"", ""unit"": ""cases per 100,000 population per year""}"
925	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	2	Case Fatality Rate, Treated																												15		10																										percentage	"{""maximum_value"": 15, ""minimum_value"": 10, ""name"": ""Case Fatality Rate, Treated"", ""unit"": ""percentage""}"	{}	"{""evidence"": [{""explanation"": ""The study focuses on Listeria monocytogenes infections and does not provide specific information on the overall case fatality rate for bacterial meningitis."", ""reference"": ""PMID:27345176"", ""snippet"": ""Invasive Listeria monocytogenes infections carry a high mortality despite antibiotic treatment."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The study mentions a case fatality rate of 15-20% in adults, which does not directly support the statement that the treated case fatality rate is between 10% and 15%."", ""reference"": ""PMID:24568594"", ""snippet"": ""INTRODUCTION: Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The study provides a case fatality rate of 32% for neonatal meningitis, which is not within the range specified in the statement."", ""reference"": ""PMID:34343128"", ""snippet"": ""The crude CFR of neonatal meningitis was 32%."", ""supports"": ""NO_EVIDENCE""}], ""maximum_value"": 15, ""minimum_value"": 10, ""name"": ""Case Fatality Rate, Treated"", ""unit"": ""percentage""}"
926	39	Bacterial meningitis	Bacterial_meningitis.yaml	epidemiology	3	Case Fatality Rate, Untreated																												100		70																										percentage	"{""maximum_value"": 100, ""minimum_value"": 70, ""name"": ""Case Fatality Rate, Untreated"", ""unit"": ""percentage""}"	{}	"{""evidence"": [{""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:36190396"", ""snippet"": ""The observed mortality was 33% (38/114 patients)."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:24568594"", ""snippet"": ""Bacterial meningitis is a serious disease with a mortality rate of 15-20% in adults."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:27345176"", ""snippet"": ""Invasive Listeria monocytogenes infections carry a high mortality despite antibiotic treatment."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:25442861"", ""snippet"": ""A total of 175 children with confirmed bacterial meningitis were enrolled."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:18254060"", ""snippet"": ""Acute bacterial meningitis remains a disease with high mortality and morbidity rates."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:34343128"", ""snippet"": ""The crude CFR of neonatal meningitis was 32%."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:20485712"", ""snippet"": ""Meningococcal disease remains a significant illness with an overall mortality of around 8%."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:20453662"", ""snippet"": ""BM in cirrhotic patients is associated with a high mortality rate."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study provides data on treated cases of bacterial meningitis, not untreated cases."", ""reference"": ""PMID:22029523"", ""snippet"": ""Despite targeted therapy, case-fatality rates and neurologic sequelae of bacterial meningitis remain unacceptably high."", ""supports"": ""NO_EVIDENCE""}], ""maximum_value"": 100, ""minimum_value"": 70, ""name"": ""Case Fatality Rate, Untreated"", ""unit"": ""percentage""}"
1138	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	epidemiology	0	High prevalence among pigeon fanciers	Pigeon fanciers have a high prevalence of bird fancier's lung in regional cohort studies.																																																								"{""description"": ""Pigeon fanciers have a high prevalence of bird fancier's lung in regional cohort studies."", ""name"": ""High prevalence among pigeon fanciers""}"	{}	"{""description"": ""Pigeon fanciers have a high prevalence of bird fancier's lung in regional cohort studies."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The study documents a high prevalence among exposed pigeon fanciers."", ""reference"": ""PMID:1053441"", ""snippet"": ""Among fifty-three Salt Lake City, Utah area pigeon fanciers, 21% were found to have the clinical picture of pigeon breeders' disease."", ""supports"": ""SUPPORT""}], ""name"": ""High prevalence among pigeon fanciers""}"
1139	47	Bird Fancier's Lung	Bird_Fanciers_Lung.yaml	epidemiology	1	Common form of hypersensitivity pneumonitis	Bird fancier's lung is a common form of hypersensitivity pneumonitis among exposed populations.																																																								"{""description"": ""Bird fancier's lung is a common form of hypersensitivity pneumonitis among exposed populations."", ""name"": ""Common form of hypersensitivity pneumonitis""}"	{}	"{""description"": ""Bird fancier's lung is a common form of hypersensitivity pneumonitis among exposed populations."", ""evidence"": [{""evidence_source"": ""HUMAN_CLINICAL"", ""explanation"": ""The review describes BFL as a very common form of HP."", ""reference"": ""PMID:21870048"", ""snippet"": ""Bird fancier's lung (BFL) resulting from avian antigen exposure is a very common form of hypersensitivity pneumonitis."", ""supports"": ""SUPPORT""}], ""name"": ""Common form of hypersensitivity pneumonitis""}"
1402	61	Cholera	Cholera.yaml	epidemiology	0	Basic Reproduction Number (R0)	The average number of secondary infections caused by one infected individual in a completely susceptible population.																											20		1					Highly variable depending on environmental and population factors. Higher in areas with poor sanitation and during initial outbreak phases.																						"{""description"": ""The average number of secondary infections caused by one infected individual in a completely susceptible population."", ""maximum_value"": 20, ""minimum_value"": 1, ""name"": ""Basic Reproduction Number (R0)"", ""notes"": ""Highly variable depending on environmental and population factors. Higher in areas with poor sanitation and during initial outbreak phases.""}"	"{""factors"": [""Population density"", ""Sanitation conditions"", ""Water quality"", ""Hygiene practices""]}"	"{""description"": ""The average number of secondary infections caused by one infected individual in a completely susceptible population."", ""evidence"": [{""explanation"": ""The abstract discusses the use of R0 in understanding disease spread but does not detail specific values or factors affecting R0 for cholera."", ""reference"": ""PMID:21860658"", ""snippet"": ""R(0) has been widely used as a measure of disease strength to estimate the effectiveness of control measures and to form the backbone of disease-management policy."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The abstract provides an overview of cholera's epidemiology but does not mention specific R0 values or the factors affecting R0."", ""reference"": ""PMID:22937199"", ""snippet"": ""The two most distinguishing epidemiologic features of the disease are its tendency to appear in explosive outbreaks and its predisposition to causing pandemics."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The abstract discusses the calculation of the basic reproduction number (R0) for a cholera model but does not mention specific values or the exact factors listed."", ""reference"": ""PMID:36654005"", ""snippet"": ""the basic reproduction number is calculated. When the basic reproduction number is less than one, the disease-free equilibrium is locally stable."", ""supports"": ""PARTIAL""}, {""explanation"": ""The abstract provides an estimated R0 value for cholera in Peru, mentioning spatial variability and correlation with geographic factors but not detailing all the factors listed in the statement."", ""reference"": ""PMID:32663235"", ""snippet"": ""The overall R0 across departments was estimated at 2.1 (95% CI: 0.8, 7.3)"", ""supports"": ""PARTIAL""}, {""explanation"": ""The abstract discusses the R0 for COVID-19, not cholera."", ""reference"": ""PMID:32678037"", ""snippet"": ""RESULTS: We estimated the exponential growth rate as 0.22 per day (95% CI: 0.20-0.24), and the basic reproduction number, R0, as 2.37 (95% CI: 2.22-2.51) based on the assumption that the exponential growth starting from 1 March 2020"", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The abstract discusses the effect of rainfall on cholera incidence but does not provide specific R0 values or detail the factors affecting R0."", ""reference"": ""PMID:18091420"", ""snippet"": ""The incidence of cholera in Bangladesh shows clear seasonality, suggesting that weather factors could play a role in its epidemiology."", ""supports"": ""NO_EVIDENCE""}], ""factors"": [""Population density"", ""Sanitation conditions"", ""Water quality"", ""Hygiene practices""], ""maximum_value"": 20, ""minimum_value"": 1, ""name"": ""Basic Reproduction Number (R0)"", ""notes"": ""Highly variable depending on environmental and population factors. Higher in areas with poor sanitation and during initial outbreak phases.""}"
1403	61	Cholera	Cholera.yaml	epidemiology	1	Effective Reproduction Number (R or Rt)	The average number of secondary cases per infectious case in a population made up of both susceptible and non-susceptible individuals.																											8		0.5					Changes over time as control measures are implemented and population immunity increases. Rt < 1 indicates declining epidemic.																						"{""description"": ""The average number of secondary cases per infectious case in a population made up of both susceptible and non-susceptible individuals."", ""maximum_value"": 8, ""minimum_value"": 0.5, ""name"": ""Effective Reproduction Number (R or Rt)"", ""notes"": ""Changes over time as control measures are implemented and population immunity increases. Rt < 1 indicates declining epidemic.""}"	"{""factors"": [""Proportion of susceptible individuals"", ""Control measures (e.g., improved sanitation, vaccination)"", ""Changes in behavior (e.g., increased hygiene practices)""]}"	"{""description"": ""The average number of secondary cases per infectious case in a population made up of both susceptible and non-susceptible individuals."", ""evidence"": [{""explanation"": ""The provided literature discusses cholera outbreaks and prevention but does not provide specific information on the effective reproduction number (R or Rt) for cholera."", ""reference"": ""PMID:34550374"", ""snippet"": ""Cholera outbreaks currently account for 1.3 to 4.0 million cases and cause between 21 000 and 143 000 deaths worldwide. Cholera is preventable by proper sanitization and immunization; however, in many developing nations such as India, cholera disease is endemic."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""While the literature defines the basic reproduction number for cholera, it does not provide specific values for the effective reproduction number (R or Rt) or discuss the factors affecting it."", ""reference"": ""PMID:24245619"", ""snippet"": ""A new model for the dynamics of cholera is formulated that incorporates both the infection age of infectious individuals and biological age of pathogen in the environment. The basic reproduction number is defined and proved to be a sharp threshold determining whether or not cholera dies out."", ""supports"": ""NO_EVIDENCE""}], ""factors"": [""Proportion of susceptible individuals"", ""Control measures (e.g., improved sanitation, vaccination)"", ""Changes in behavior (e.g., increased hygiene practices)""], ""maximum_value"": 8, ""minimum_value"": 0.5, ""name"": ""Effective Reproduction Number (R or Rt)"", ""notes"": ""Changes over time as control measures are implemented and population immunity increases. Rt < 1 indicates declining epidemic.""}"
1404	61	Cholera	Cholera.yaml	epidemiology	2	Serial Interval	The time between the onset of symptoms in a primary case and the onset of symptoms in secondary cases.																											10	3-5	1					Important for estimating R and modeling the speed of epidemic spread.																					days	"{""description"": ""The time between the onset of symptoms in a primary case and the onset of symptoms in secondary cases."", ""maximum_value"": 10, ""mean_range"": ""3-5"", ""minimum_value"": 1, ""name"": ""Serial Interval"", ""notes"": ""Important for estimating R and modeling the speed of epidemic spread."", ""unit"": ""days""}"	{}	"{""description"": ""The time between the onset of symptoms in a primary case and the onset of symptoms in secondary cases."", ""evidence"": [{""explanation"": ""The reference discusses the change in reported cholera cases following a natural disaster, but does not provide information about the serial interval of cholera."", ""reference"": ""PMID:30594260"", ""snippet"": ""To evaluate the change in reported cholera cases following Hurricane Matthew on reported cholera cases, we used interrupted time series regression models of daily reported cholera cases, controlling for the impact of both rainfall, following a 4-week lag, and seasonality, from 2013 through 2016."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""Although the reference discusses cholera transmission models, it does not provide data on the serial interval of cholera."", ""reference"": ""PMID:36654005"", ""snippet"": ""In this paper, we consider an age-structured cholera model with saturation incidence, vaccination age of vaccinated individuals, infection age of infected individuals, and biological age of pathogens."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This reference addresses the impact of incubation periods on the spread and predictability of outbreaks, but does not detail the serial interval for cholera."", ""reference"": ""PMID:32054785"", ""snippet"": ""We develop a simulation model of the spatial spread of an epidemic in order to examine the impact of a pathogen's incubation period on the dynamics of spread and the predictability of outbreaks."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""The study provides data on influenza epidemiology, not cholera, and does not mention serial interval."", ""reference"": ""PMID:30114215"", ""snippet"": ""We use approximate Bayesian computation to estimate parameters in a climate-driven stochastic epidemic model, including the basic reproduction number R0."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""Although this refers to cholera research, it does not provide specific information about the serial interval of cholera."", ""reference"": ""PMID:21415490"", ""snippet"": ""The enormity of human sufferings led clinicians and scientists to carry out extensive research on cholera and Vibrio cholerae (the causative bacterium of the disease), leading to major discoveries."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This reference discusses real-time disease modeling with a focus on HIV/AIDS and COVID-19, not cholera."", ""reference"": ""PMID:34995131"", ""snippet"": ""We review methods, applications, challenges and opportunities for real-time infectious disease modeling during public health emergencies, with examples drawn from the two deadliest pandemics in recent history: HIV/AIDS and coronavirus disease 2019 (COVID-19)."", ""supports"": ""NO_EVIDENCE""}], ""maximum_value"": 10, ""mean_range"": ""3-5"", ""minimum_value"": 1, ""name"": ""Serial Interval"", ""notes"": ""Important for estimating R and modeling the speed of epidemic spread."", ""unit"": ""days""}"
1405	61	Cholera	Cholera.yaml	epidemiology	3	Generation Time	The time between the infection of a primary case and the infection of secondary cases.																											9	2-4	1					Often shorter than the serial interval due to potential pre-symptomatic transmission.																					days	"{""description"": ""The time between the infection of a primary case and the infection of secondary cases."", ""maximum_value"": 9, ""mean_range"": ""2-4"", ""minimum_value"": 1, ""name"": ""Generation Time"", ""notes"": ""Often shorter than the serial interval due to potential pre-symptomatic transmission."", ""unit"": ""days""}"	{}	"{""description"": ""The time between the infection of a primary case and the infection of secondary cases."", ""evidence"": [{""explanation"": ""The literature provides information about the generation time and incubation period of measles, not cholera."", ""reference"": ""PMID:21704640"", ""snippet"": ""We have quantified a joint distribution of generation time and incubation period by a novel estimation method for household data with two susceptible individuals, consisting of time intervals between disease onsets of two measles cases."", ""supports"": ""NO_EVIDENCE""}], ""maximum_value"": 9, ""mean_range"": ""2-4"", ""minimum_value"": 1, ""name"": ""Generation Time"", ""notes"": ""Often shorter than the serial interval due to potential pre-symptomatic transmission."", ""unit"": ""days""}"
1406	61	Cholera	Cholera.yaml	epidemiology	4	Case Fatality Rate (CFR), untreated																												50		25					Varies significantly based on access to treatment and quality of care.																					percentage	"{""maximum_value"": 50, ""minimum_value"": 25, ""name"": ""Case Fatality Rate (CFR), untreated"", ""notes"": ""Varies significantly based on access to treatment and quality of care."", ""unit"": ""percentage""}"	{}	"{""evidence"": [{""explanation"": ""This shows variability in CFR. Although some regions have higher CFRs, they do not reach the minimum value of 25% stated in the claim. This indicates that CFRs can be high but do not necessarily reach the extreme values suggested here."", ""reference"": ""PMID:9260522"", ""snippet"": ""The CFR in Africa reached 5.7%, representing the highest figure in all the regions"", ""supports"": ""PARTIAL""}], ""maximum_value"": 50, ""minimum_value"": 25, ""name"": ""Case Fatality Rate (CFR), untreated"", ""notes"": ""Varies significantly based on access to treatment and quality of care."", ""unit"": ""percentage""}"
1407	61	Cholera	Cholera.yaml	epidemiology	5	Case Fatality Rate (CFR), treated																												1							Varies significantly based on access to treatment and quality of care.																					percentage	"{""maximum_value"": 1, ""name"": ""Case Fatality Rate (CFR), treated"", ""notes"": ""Varies significantly based on access to treatment and quality of care."", ""unit"": ""percentage""}"	{}	"{""evidence"": [{""explanation"": ""The literature indicates a wide range of CFRs, which aligns with the notion that it varies significantly based on access to treatment and quality of care, but it does not provide specific data about the maximum value of 1% in treated cases."", ""reference"": ""PMID:24101648"", ""snippet"": ""District CFRs ranged from 0% to 14.3%."", ""supports"": ""PARTIAL""}, {""explanation"": ""This implies variability in CFR based on care access but does not provide explicit maximum CFR values for treated cases."", ""reference"": ""PMID:30184102"", ""snippet"": ""Cholera impacts communities already burdened by conflict, lack of infrastructure, poor health systems, and malnutrition."", ""supports"": ""PARTIAL""}], ""maximum_value"": 1, ""name"": ""Case Fatality Rate (CFR), treated"", ""notes"": ""Varies significantly based on access to treatment and quality of care."", ""unit"": ""percentage""}"
1408	61	Cholera	Cholera.yaml	epidemiology	6	Infectivity Period																												10		1					Can be longer in asymptomatic carriers. Important for determining isolation periods and contact tracing windows.																					days	"{""maximum_value"": 10, ""minimum_value"": 1, ""name"": ""Infectivity Period"", ""notes"": ""Can be longer in asymptomatic carriers. Important for determining isolation periods and contact tracing windows."", ""unit"": ""days""}"	{}	"{""evidence"": [{""explanation"": ""The literature indicates an average infectivity period of around 2 days, with some individuals shedding bacteria for 4 or more days, thus partially aligning with the statement's range of 1-10 days."", ""reference"": ""PMID:25114012"", ""snippet"": ""The average length of bacterial shedding was 2.0 days (95% confidence interval 1.7-2.4). However, 16 (5%) of 294 contacts shed V. cholerae for >/= 4 days."", ""supports"": ""PARTIAL""}, {""explanation"": ""This estimate focuses on the incubation period rather than the entire infectivity period, providing partial support for the statement’s range of 1-10 days."", ""reference"": ""PMID:23201968"", ""snippet"": ""We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6)... 95% by 4.4 days (95% CI 3.9-5.0) after infection."", ""supports"": ""PARTIAL""}, {""explanation"": ""The infectivity period is implied to have variability, including asymptomatic carriers, but specific durations are not explicitly detailed, offering partial support."", ""reference"": ""PMID:37961651"", ""snippet"": ""Most infections with pandemic Vibrio cholerae are thought to result in subclinical disease and are not captured by surveillance. Previous estimates of the ratio of infections to clinical cases have varied widely (2 to 100)."", ""supports"": ""PARTIAL""}], ""maximum_value"": 10, ""minimum_value"": 1, ""name"": ""Infectivity Period"", ""notes"": ""Can be longer in asymptomatic carriers. Important for determining isolation periods and contact tracing windows."", ""unit"": ""days""}"
1409	61	Cholera	Cholera.yaml	epidemiology	7	Peak Infectivity post symptom onset																												5		3																										days	"{""maximum_value"": 5, ""minimum_value"": 3, ""name"": ""Peak Infectivity post symptom onset"", ""unit"": ""days""}"	{}	"{""evidence"": [{""explanation"": ""The data indicates that the peak infectivity of cholera post symptom onset occurs between 3 and 5 days."", ""reference"": ""PMID:23201968"", ""snippet"": ""We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection."", ""supports"": ""SUPPORT""}], ""maximum_value"": 5, ""minimum_value"": 3, ""name"": ""Peak Infectivity post symptom onset"", ""unit"": ""days""}"
1410	61	Cholera	Cholera.yaml	epidemiology	8	Incubation Period																												5	2-3	0					Affects the timing of symptom onset and the implementation of control measures.																					days	"{""maximum_value"": 5, ""mean_range"": ""2-3"", ""minimum_value"": 0, ""name"": ""Incubation Period"", ""notes"": ""Affects the timing of symptom onset and the implementation of control measures."", ""unit"": ""days""}"	{}	"{""evidence"": [{""explanation"": ""The statement indicates a mean incubation period range of 2-3 days, whereas the median and the 95th percentile in the literature slightly differ from these ranges. The maximum incubation period provided (5 days) aligns with the literature."", ""reference"": ""PMID:23201968"", ""snippet"": ""We estimate the median incubation period of toxigenic cholera to be 1.4 days (95% CI, 1.3-1.6). Five percent of cholera cases will develop symptoms by 0.5 days (95% CI 0.4-0.5), and 95% by 4.4 days (95% CI 3.9-5.0) after infection."", ""supports"": ""PARTIAL""}], ""maximum_value"": 5, ""mean_range"": ""2-3"", ""minimum_value"": 0, ""name"": ""Incubation Period"", ""notes"": ""Affects the timing of symptom onset and the implementation of control measures."", ""unit"": ""days""}"
1411	61	Cholera	Cholera.yaml	epidemiology	9	Attack Rate, typical	The proportion of susceptible individuals who become ill during a specified time interval.																											2		0.1					Varies widely depending on environmental conditions and population susceptibility.																					percentage	"{""description"": ""The proportion of susceptible individuals who become ill during a specified time interval."", ""maximum_value"": 2, ""minimum_value"": 0.1, ""name"": ""Attack Rate, typical"", ""notes"": ""Varies widely depending on environmental conditions and population susceptibility."", ""unit"": ""percentage""}"	{}	"{""description"": ""The proportion of susceptible individuals who become ill during a specified time interval."", ""evidence"": [{""explanation"": ""The attack rate given in the reference is not directly expressing the percentage range specified in the statement (0.1 to 2 percent)."", ""reference"": ""PMID:36123095"", ""snippet"": ""The overall AR was 46.5 per 100 000 persons. The North-West region recorded the highest AR with 102 per 100 000."", ""supports"": ""NO_EVIDENCE""}], ""maximum_value"": 2, ""minimum_value"": 0.1, ""name"": ""Attack Rate, typical"", ""notes"": ""Varies widely depending on environmental conditions and population susceptibility."", ""unit"": ""percentage""}"
1412	61	Cholera	Cholera.yaml	epidemiology	10	Attack Rate, severe	The proportion of susceptible individuals who become ill during a specified time interval.																											10		5					Varies widely depending on environmental conditions and population susceptibility.																					percentage	"{""description"": ""The proportion of susceptible individuals who become ill during a specified time interval."", ""maximum_value"": 10, ""minimum_value"": 5, ""name"": ""Attack Rate, severe"", ""notes"": ""Varies widely depending on environmental conditions and population susceptibility."", ""unit"": ""percentage""}"	{}	"{""description"": ""The proportion of susceptible individuals who become ill during a specified time interval."", ""evidence"": [{""explanation"": ""The literature provides the median attack rate in per 1000 people, not percentages, and does not specify a range of 5%-10%. It mentions attack rates in terms of per thousand people which is not directly related to the percentages specified in the statement."", ""reference"": ""PMID:35605949"", ""snippet"": ""The outbreak periods accounted for 1.8 billion person-months (2% of the total during this period) from January 2010 to January 2020. Among 692 outbreaks reported from second-level administrative units (e.g., districts), the median attack rate was 0.8 per 1000 people (interquartile range (IQR), 0.3-2.4 per 1000), the median epidemic duration was 13 weeks (IQR, 8-19), and the median early outbreak reproductive number was 1.8 (range, 1.1-3.5). Larger attack rates were associated with longer times to outbreak peak, longer epidemic durations, and lower case fatality risks."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This reference discusses the ratio of infections to clinical cases rather than specifying the attack rate range in percentages as stated in the claim."", ""reference"": ""PMID:37961651"", ""snippet"": ""Understanding cholera epidemiology and immunity relies on the ability to translate between numbers of clinical cases and the underlying number of infections in the population. We estimated the infection incidence during the first months of an outbreak in a cholera-naive population using a Bayesian vibriocidal antibody titer decay model combining measurements from a representative serosurvey and clinical surveillance data."", ""supports"": ""NO_EVIDENCE""}], ""maximum_value"": 10, ""minimum_value"": 5, ""name"": ""Attack Rate, severe"", ""notes"": ""Varies widely depending on environmental conditions and population susceptibility."", ""unit"": ""percentage""}"
1413	61	Cholera	Cholera.yaml	epidemiology	11	Asymptomatic Ratio	The proportion of infected individuals who do not display symptoms.																											80		10					Highly variable and challenging to measure accurately. Critical for understanding true disease spread and implementing control measures.																					percentage	"{""description"": ""The proportion of infected individuals who do not display symptoms."", ""maximum_value"": 80, ""minimum_value"": 10, ""name"": ""Asymptomatic Ratio"", ""notes"": ""Highly variable and challenging to measure accurately. Critical for understanding true disease spread and implementing control measures."", ""unit"": ""percentage""}"	{}	"{""description"": ""The proportion of infected individuals who do not display symptoms."", ""evidence"": [{""explanation"": ""The study highlights that the asymptomatic ratio in cholera is much higher than previous estimates and provides evidence that it is critical for understanding cholera transmission dynamics."", ""reference"": ""PMID:18704085"", ""snippet"": ""Here we show that a model incorporating high asymptomatic ratio ... We find that the asymptomatic ratio in cholera is far higher than had been previously supposed."", ""supports"": ""SUPPORT""}, {""explanation"": ""The study suggests the presence of a significant asymptomatic population that is crucial in the spread and endemicity of cholera."", ""reference"": ""PMID:32529415"", ""snippet"": ""They indicate the existence of bacteria and asymptomatic individuals in the population of Senegal at any single time."", ""supports"": ""SUPPORT""}, {""explanation"": ""Although this study documents asymptomatic cases, it does not provide specific support for the general asymptomatic ratio range (10-80%)."", ""reference"": ""PMID:2341728"", ""snippet"": ""A total of 74 inmates (18 symptomatic and 56 asymptomatic) were infected."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This study touches on the role of prognostic indices in understanding outbreaks but does not directly address the asymptomatic ratio range specified (10-80%)."", ""reference"": ""PMID:35259956"", ""snippet"": ""Prognostic metrics of unfolding outbreaks are of particular importance."", ""supports"": ""PARTIAL""}], ""maximum_value"": 80, ""minimum_value"": 10, ""name"": ""Asymptomatic Ratio"", ""notes"": ""Highly variable and challenging to measure accurately. Critical for understanding true disease spread and implementing control measures."", ""unit"": ""percentage""}"
1520	65	Chronic Lymphocytic Leukemia	Chronic_Lymphocytic_Leukemia.yaml	epidemiology	0	Most common adult leukemia	Chronic lymphocytic leukemia is the most common type of leukemia in adults.																																																								"{""description"": ""Chronic lymphocytic leukemia is the most common type of leukemia in adults."", ""name"": ""Most common adult leukemia""}"	{}	"{""description"": ""Chronic lymphocytic leukemia is the most common type of leukemia in adults."", ""evidence"": [{""explanation"": ""This abstract explicitly states that CLL is the most common adult leukemia."", ""reference"": ""PMID:41572562"", ""snippet"": ""Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults."", ""supports"": ""SUPPORT""}], ""name"": ""Most common adult leukemia""}"
2053	91	Diffuse Large B-Cell Lymphoma	Diffuse_Large_B_Cell_Lymphoma.yaml	epidemiology	0	Most common non-Hodgkin lymphoma	Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma.																																																								"{""description"": ""Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma."", ""name"": ""Most common non-Hodgkin lymphoma""}"	{}	"{""description"": ""Diffuse large B-cell lymphoma is the most common type of non-Hodgkin lymphoma."", ""evidence"": [{""explanation"": ""This abstract explicitly identifies DLBCL as the most common type of NHL."", ""reference"": ""PMID:40753559"", ""snippet"": ""Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL)."", ""supports"": ""SUPPORT""}], ""name"": ""Most common non-Hodgkin lymphoma""}"
2528	111	FICUS syndrome	FICUS_syndrome.yaml	epidemiology	0	Prevalence range of psychological outcomes in ICU family caregivers	"Systematic review reporting wide ranges in prevalence estimates for depression, anxiety, and PTSD among family caregivers of critically ill ICU patients across studies.
"																											94		2					Ranges reported across included studies; depression 4%–94%, anxiety 2%–80%, PTSD 3%–62%.																					percentage	"{""description"": ""Systematic review reporting wide ranges in prevalence estimates for depression, anxiety, and PTSD among family caregivers of critically ill ICU patients across studies.\n"", ""maximum_value"": 94, ""minimum_value"": 2, ""name"": ""Prevalence range of psychological outcomes in ICU family caregivers"", ""notes"": ""Ranges reported across included studies; depression 4%–94%, anxiety 2%–80%, PTSD 3%–62%."", ""unit"": ""percentage""}"	{}	"{""description"": ""Systematic review reporting wide ranges in prevalence estimates for depression, anxiety, and PTSD among family caregivers of critically ill ICU patients across studies.\n"", ""evidence"": [{""explanation"": ""This provides prevalence ranges across studies for key psychological outcomes in ICU family caregivers."", ""reference"": ""PMID:30950647"", ""snippet"": ""The prevalence of psychological outcomes in family caregivers ranged from 4% to 94% for depression, 2% to 80% for anxiety, and 3% to 62% for PTSD."", ""supports"": ""SUPPORT""}], ""maximum_value"": 94, ""minimum_value"": 2, ""name"": ""Prevalence range of psychological outcomes in ICU family caregivers"", ""notes"": ""Ranges reported across included studies; depression 4%–94%, anxiety 2%–80%, PTSD 3%–62%."", ""unit"": ""percentage""}"
2529	111	FICUS syndrome	FICUS_syndrome.yaml	epidemiology	1	Risk factors for psychological outcomes in ICU family caregivers	"Systematic review identifying common risk factors for adverse psychological outcomes among family caregivers of critically ill ICU patients.
"																																																								"{""description"": ""Systematic review identifying common risk factors for adverse psychological outcomes among family caregivers of critically ill ICU patients.\n"", ""name"": ""Risk factors for psychological outcomes in ICU family caregivers""}"	"{""factors"": [""Younger caregiver age"", ""Caregiver relationship to the patient"", ""Lower socioeconomic status"", ""Female sex""]}"	"{""description"": ""Systematic review identifying common risk factors for adverse psychological outcomes among family caregivers of critically ill ICU patients.\n"", ""evidence"": [{""explanation"": ""This review lists common risk factors associated with psychological outcomes in ICU family caregivers."", ""reference"": ""PMID:30950647"", ""snippet"": ""Common risk factors identified for adverse psychological outcomes included younger caregiver age, caregiver relationship to the patient, lower socioeconomic status, and female sex."", ""supports"": ""SUPPORT""}], ""factors"": [""Younger caregiver age"", ""Caregiver relationship to the patient"", ""Lower socioeconomic status"", ""Female sex""], ""name"": ""Risk factors for psychological outcomes in ICU family caregivers""}"
3119	131	Glioblastoma, IDH-Wildtype	Glioblastoma_IDH_Wildtype.yaml	epidemiology	0	Most common primary malignant brain tumor	Glioblastoma is the most common and most malignant primary brain tumor in adults.																																																								"{""description"": ""Glioblastoma is the most common and most malignant primary brain tumor in adults."", ""name"": ""Most common primary malignant brain tumor""}"	{}	"{""description"": ""Glioblastoma is the most common and most malignant primary brain tumor in adults."", ""evidence"": [{""explanation"": ""This abstract explicitly identifies IDH-wildtype glioblastoma as the most common and most malignant primary brain tumor."", ""reference"": ""PMID:41569770"", ""snippet"": ""Glioblastoma, isocitrate dehydrogenase-wildtype CNS WHO grade 4 (formerly primary glioblastoma multiforme), is the most common and most malignant primary brain tumor."", ""supports"": ""SUPPORT""}], ""name"": ""Most common primary malignant brain tumor""}"
3581	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	0	Basic Reproduction Number (R0)	The average number of secondary infections caused by one infected individual in a completely susceptible population.																											10		2					Highly variable based on geographic region, vaccination rates, and modes of transmission.																						"{""description"": ""The average number of secondary infections caused by one infected individual in a completely susceptible population."", ""maximum_value"": 10, ""minimum_value"": 2, ""name"": ""Basic Reproduction Number (R0)"", ""notes"": ""Highly variable based on geographic region, vaccination rates, and modes of transmission.""}"	"{""factors"": [""Vaccination coverage"", ""Healthcare practices"", ""Population mobility""]}"	"{""description"": ""The average number of secondary infections caused by one infected individual in a completely susceptible population."", ""evidence"": [{""explanation"": ""The reference discusses the calculation of the basic reproduction number (R0) for Hepatitis B, which supports the statement about the importance of R0. However, it does not provide specific values for the maximum and minimum R0."", ""reference"": ""PMID:37322965"", ""snippet"": ""In this regard, we first calculate the basic reproduction number and the equilibrium points of the deterministic Hepatitis B model."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference provides epidemiological data on Hepatitis B but does not discuss the basic reproduction number (R0) or its variability."", ""reference"": ""PMID:16754644"", ""snippet"": ""Worldwide, two billion people have been infected with hepatitis B virus (HBV), 360 million have chronic infection, and 600,000 die each year from HBV-related liver disease or hepatocellular carcinoma."", ""supports"": ""NO_EVIDENCE""}, {""explanation"": ""This reference focuses on the determinants of transmission of bloodborne pathogens, including Hepatitis B, but does not provide information on the basic reproduction number (R0)."", ""reference"": ""PMID:7713188"", ""snippet"": ""The key determinants of transmission of bloodborne pathogens are the dose and serum viral concentration of an exposure."", ""supports"": ""NO_EVIDENCE""}], ""factors"": [""Vaccination coverage"", ""Healthcare practices"", ""Population mobility""], ""maximum_value"": 10, ""minimum_value"": 2, ""name"": ""Basic Reproduction Number (R0)"", ""notes"": ""Highly variable based on geographic region, vaccination rates, and modes of transmission.""}"
3582	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	1	Effective Reproduction Number (R or Rt)	The average number of secondary cases per infectious case in a population with some immunity or control measures.																											1.2		0.3					Decreases with effective vaccination and antiviral therapies.																						"{""description"": ""The average number of secondary cases per infectious case in a population with some immunity or control measures."", ""maximum_value"": 1.2, ""minimum_value"": 0.3, ""name"": ""Effective Reproduction Number (R or Rt)"", ""notes"": ""Decreases with effective vaccination and antiviral therapies.""}"	"{""factors"": [""Proportion of immune individuals"", ""Effectiveness of antiviral treatment""]}"	"{""description"": ""The average number of secondary cases per infectious case in a population with some immunity or control measures."", ""evidence"": [{""explanation"": ""The reference discusses control strategies to reduce HBV transmission, which indirectly supports the idea that the effective reproduction number (R or Rt) decreases with effective vaccination and antiviral therapies. However, it does not provide specific values for the effective reproduction number."", ""reference"": ""PMID:37322965"", ""snippet"": ""To reduce Hepatitis B infection rates and to promote vaccination rates, three control variables are used, for instance, isolation of patients, treatment of patients, and vaccine inoculation."", ""supports"": ""PARTIAL""}], ""factors"": [""Proportion of immune individuals"", ""Effectiveness of antiviral treatment""], ""maximum_value"": 1.2, ""minimum_value"": 0.3, ""name"": ""Effective Reproduction Number (R or Rt)"", ""notes"": ""Decreases with effective vaccination and antiviral therapies.""}"
3583	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	2	Incubation Period																												180	60-90	30					Affects the timing of infection control measures and contact tracing.																					days	"{""maximum_value"": 180, ""mean_range"": ""60-90"", ""minimum_value"": 30, ""name"": ""Incubation Period"", ""notes"": ""Affects the timing of infection control measures and contact tracing."", ""unit"": ""days""}"	{}	"{""evidence"": [{""explanation"": ""The paper discusses a model that includes the incubation period of Hepatitis B, which aligns with the provided statement."", ""reference"": ""PMID:29260504"", ""snippet"": ""a hepatitis B virus (HBV) model with an incubation period and delayed state and control variables is firstly proposed."", ""supports"": ""SUPPORT""}], ""maximum_value"": 180, ""mean_range"": ""60-90"", ""minimum_value"": 30, ""name"": ""Incubation Period"", ""notes"": ""Affects the timing of infection control measures and contact tracing."", ""unit"": ""days""}"
3584	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	3	Chronic Carriage Rate	The percentage of infected individuals who develop chronic hepatitis B infection.																											10		2					Higher in infants and young children than in adults.																					percentage	"{""description"": ""The percentage of infected individuals who develop chronic hepatitis B infection."", ""maximum_value"": 10, ""minimum_value"": 2, ""name"": ""Chronic Carriage Rate"", ""notes"": ""Higher in infants and young children than in adults."", ""unit"": ""percentage""}"	{}	"{""description"": ""The percentage of infected individuals who develop chronic hepatitis B infection."", ""evidence"": [{""explanation"": ""The statement is partially supported as it mentions that 5-10% of adults develop chronic hepatitis B infection, which falls within the 2-10% range. However, it also states that up to 90% of infants can become chronically infected, which is not captured in the statement."", ""reference"": ""PMID:11197043"", ""snippet"": ""Of the estimated 50 million new cases of hepatitis B virus (HBV) infection diagnosed annually, 5-10% of adults and up to 90% of infants will become chronically infected."", ""supports"": ""PARTIAL""}, {""explanation"": ""The statement is partially supported as it mentions that infants have up to 90% risk of developing chronic HBV infection, but does not provide specific percentages for adults."", ""reference"": ""PMID:12616451"", ""snippet"": ""Infants who acquire HBV perinatally have up to 90% risk of developing chronic HBV infection."", ""supports"": ""PARTIAL""}, {""explanation"": ""This reference discusses the role of carrier individuals in the transmission of hepatitis B but does not provide specific percentages for chronic carriage rates."", ""reference"": ""PMID:29202763"", ""snippet"": ""Carrier individuals are especially significant, because they do not exhibit any symptoms and are able to transmit the infection."", ""supports"": ""NO_EVIDENCE""}], ""maximum_value"": 10, ""minimum_value"": 2, ""name"": ""Chronic Carriage Rate"", ""notes"": ""Higher in infants and young children than in adults."", ""unit"": ""percentage""}"
3585	151	Hepatitis B	Hepatitis_B.yaml	epidemiology	4	Asymptomatic Ratio	The proportion of infected individuals who do not display symptoms.																											70		50					Important for understanding true disease prevalence and silent spreaders.																					percentage	"{""description"": ""The proportion of infected individuals who do not display symptoms."", ""maximum_value"": 70, ""minimum_value"": 50, ""name"": ""Asymptomatic Ratio"", ""notes"": ""Important for understanding true disease prevalence and silent spreaders."", ""unit"": ""percentage""}"	{}	"{""description"": ""The proportion of infected individuals who do not display symptoms."", ""evidence"": [{""explanation"": ""The study indicates a high exposure rate to HBV, with a significant proportion of individuals being asymptomatic carriers. However, it does not provide a specific percentage range for asymptomatic individuals."", ""reference"": ""PMID:23185500"", ""snippet"": ""Of 117 participants, 90% of recipients exhibited evidence of exposure to HBV, 42% with HBsAg and/or HBV DNA and 48% anti-HBc reactive without detectable HBV DNA."", ""supports"": ""PARTIAL""}, {""explanation"": ""The literature mentions that many children with chronic HBV infection are asymptomatic, but it does not specify the exact proportion of asymptomatic cases."", ""reference"": ""PMID:12616451"", ""snippet"": ""Many HBV-infected children have normal alanine aminotransferase values and minimal chronic hepatitis. Children with chronic HBV infection are usually asymptomatic but may develop chronic liver disease or hepatocellular carcinoma."", ""supports"": ""PARTIAL""}], ""maximum_value"": 70, ""minimum_value"": 50, ""name"": ""Asymptomatic Ratio"", ""notes"": ""Important for understanding true disease prevalence and silent spreaders."", ""unit"": ""percentage""}"
4491	189	Ludwig's Angina	Ludwigs_Angina.yaml	epidemiology	0	Incidence Before vs During COVID-19 (Single Center)																												0.04		0.02																										cases per year (per ED dental infection evaluations)	"{""maximum_value"": 0.04, ""minimum_value"": 0.02, ""name"": ""Incidence Before vs During COVID-19 (Single Center)"", ""unit"": ""cases per year (per ED dental infection evaluations)""}"	{}	"{""evidence"": [{""explanation"": ""Washington University single-center data showed incidence doubling during COVID-onset vs pre-COVID periods when dental care was delayed."", ""reference"": ""PMID:37944093"", ""snippet"": ""In the pre-COVID group, we identified 32 of 1,301 patients with LA for an incidence of 0.02 per year... The COVID-onset group consisted of 41 of 641 patients, with an incidence of 0.04 per year."", ""supports"": ""SUPPORT""}], ""maximum_value"": 0.04, ""minimum_value"": 0.02, ""name"": ""Incidence Before vs During COVID-19 (Single Center)"", ""unit"": ""cases per year (per ED dental infection evaluations)""}"
4492	189	Ludwig's Angina	Ludwigs_Angina.yaml	epidemiology	1	Case Fatality Range Across Nigerian Centers																												19		4																										percent case fatality	"{""maximum_value"": 19, ""minimum_value"": 4, ""name"": ""Case Fatality Range Across Nigerian Centers"", ""unit"": ""percent case fatality""}"	{}	"{""evidence"": [{""explanation"": ""Multi-center Nigerian series reports mortality spanning 4–19% depending on center."", ""reference"": ""PMID:34187738"", ""snippet"": ""Mortality ranged from 4% in Benin to 12% in Lagos and it was as high as 19% in Kano."", ""supports"": ""SUPPORT""}], ""maximum_value"": 19, ""minimum_value"": 4, ""name"": ""Case Fatality Range Across Nigerian Centers"", ""unit"": ""percent case fatality""}"
4493	189	Ludwig's Angina	Ludwigs_Angina.yaml	epidemiology	2	Diabetes Prevalence (Lagos Subset)																												21		21																										percent of cases with diabetes	"{""maximum_value"": 21, ""minimum_value"": 21, ""name"": ""Diabetes Prevalence (Lagos Subset)"", ""unit"": ""percent of cases with diabetes""}"	{}	"{""evidence"": [{""explanation"": ""Lagos cohort reports 21% of Ludwig's angina patients had diabetes."", ""reference"": ""PMID:34187738"", ""snippet"": ""Diabetes was the most prevalent underlying systematic condition, affecting 21% of the Ludwig's angina patients in Lagos."", ""supports"": ""SUPPORT""}], ""maximum_value"": 21, ""minimum_value"": 21, ""name"": ""Diabetes Prevalence (Lagos Subset)"", ""unit"": ""percent of cases with diabetes""}"
5022	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	0	Age of Onset	Typical age range for Melkersson-Rosenthal syndrome presentation																											39	Second decade of life (10-20 years)	14					"Mean onset frequently in the second decade. However, cases have been reported across a wide age range from childhood to adulthood. The classic triad may not be fully apparent at disease onset, leading to delayed diagnosis.
"																					years	"{""description"": ""Typical age range for Melkersson-Rosenthal syndrome presentation"", ""maximum_value"": 39, ""mean_range"": ""Second decade of life (10-20 years)"", ""minimum_value"": 14, ""name"": ""Age of Onset"", ""notes"": ""Mean onset frequently in the second decade. However, cases have been reported across a wide age range from childhood to adulthood. The classic triad may not be fully apparent at disease onset, leading to delayed diagnosis.\n"", ""unit"": ""years""}"	{}	"{""description"": ""Typical age range for Melkersson-Rosenthal syndrome presentation"", ""evidence"": [{""explanation"": ""Documents MRS onset in childhood/adolescence in a clinical case"", ""reference"": ""PMID:31466978"", ""snippet"": ""he exhibited recurrent facial nerve palsy since the age of 10 years"", ""supports"": ""SUPPORT""}, {""explanation"": ""Identifies Melkersson-Rosenthal syndrome as a recognized cause of facial palsy in children, establishing pediatric presentation"", ""reference"": ""PMID:36532829"", ""snippet"": ""57 children under 18 years of age diagnosed with peripheral facial nerve palsy at Çukurova University... categorized into many groups by etiology... Melkersson-Rosenthal syndrome"", ""supports"": ""SUPPORT""}, {""explanation"": ""Establishes that granulomatous diseases including MRS have age-related presentation patterns"", ""reference"": ""PMID:29191347"", ""snippet"": ""Granulomatous diseases represent a heterogeneous group of conditions characterized by histiocytic inflammation that affect patients of any age... with particular emphasis on age-related differences in the onset, epidemiology, clinical manifestations, prognosis"", ""supports"": ""SUPPORT""}], ""maximum_value"": 39, ""mean_range"": ""Second decade of life (10-20 years)"", ""minimum_value"": 14, ""name"": ""Age of Onset"", ""notes"": ""Mean onset frequently in the second decade. However, cases have been reported across a wide age range from childhood to adulthood. The classic triad may not be fully apparent at disease onset, leading to delayed diagnosis.\n"", ""unit"": ""years""}"
5023	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	1	Incidence Rate	Annual incidence of Melkersson-Rosenthal syndrome in the general population																											80		0.2					"Wide variability in reported incidence rates (0.2–80 per 100,000/year) depending on population studied, diagnostic criteria, and case finding methodology. Higher rates may reflect increased awareness and diagnostic recognition. Diagnostic underrecognition and delayed diagnosis are common, particularly when only monosymptomatic variants (e.g., isolated cheilitis) are present.
"																					per 100,000 per year	"{""description"": ""Annual incidence of Melkersson-Rosenthal syndrome in the general population"", ""maximum_value"": 80, ""minimum_value"": 0.2, ""name"": ""Incidence Rate"", ""notes"": ""Wide variability in reported incidence rates (0.2–80 per 100,000/year) depending on population studied, diagnostic criteria, and case finding methodology. Higher rates may reflect increased awareness and diagnostic recognition. Diagnostic underrecognition and delayed diagnosis are common, particularly when only monosymptomatic variants (e.g., isolated cheilitis) are present.\n"", ""unit"": ""per 100,000 per year""}"	{}	"{""description"": ""Annual incidence of Melkersson-Rosenthal syndrome in the general population"", ""evidence"": [{""explanation"": ""Establishes that MRS/granulomatous cheilitis is a rare disease with low population incidence"", ""reference"": ""PMID:22657098"", ""snippet"": ""Granulomatous cheilitis is a rare disease."", ""supports"": ""SUPPORT""}, {""explanation"": ""Supports that MRS as a granulomatous disease has variable epidemiology depending on population and recognition factors"", ""reference"": ""PMID:29191347"", ""snippet"": ""Granulomatous diseases represent a heterogeneous group of conditions characterized by histiocytic inflammation that affect patients of any age"", ""supports"": ""PARTIAL""}], ""maximum_value"": 80, ""minimum_value"": 0.2, ""name"": ""Incidence Rate"", ""notes"": ""Wide variability in reported incidence rates (0.2–80 per 100,000/year) depending on population studied, diagnostic criteria, and case finding methodology. Higher rates may reflect increased awareness and diagnostic recognition. Diagnostic underrecognition and delayed diagnosis are common, particularly when only monosymptomatic variants (e.g., isolated cheilitis) are present.\n"", ""unit"": ""per 100,000 per year""}"
5024	211	Melkersson-Rosenthal syndrome	Melkersson_Rosenthal_syndrome.yaml	epidemiology	2	Frequency of Complete Triad	Percentage of MRS patients presenting with all three features of the classic triad																											25		8					"Only 8–25% of MRS cases present with the complete classic triad (recurrent orofacial edema, facial nerve paralysis, fissured tongue). Many patients present with monosymptomatic or oligosymptomatic variants, particularly isolated granulomatous cheilitis, leading to diagnostic delays.
"																					percent	"{""description"": ""Percentage of MRS patients presenting with all three features of the classic triad"", ""maximum_value"": 25, ""minimum_value"": 8, ""name"": ""Frequency of Complete Triad"", ""notes"": ""Only 8–25% of MRS cases present with the complete classic triad (recurrent orofacial edema, facial nerve paralysis, fissured tongue). Many patients present with monosymptomatic or oligosymptomatic variants, particularly isolated granulomatous cheilitis, leading to diagnostic delays.\n"", ""unit"": ""percent""}"	{}	"{""description"": ""Percentage of MRS patients presenting with all three features of the classic triad"", ""evidence"": [{""explanation"": ""Confirms that the complete triad occurs in only a minority of MRS cases"", ""reference"": ""PMID:31466978"", ""snippet"": ""This case is particularly rare, as the classic triad is seen only in a minority of the cases."", ""supports"": ""SUPPORT""}, {""explanation"": ""Demonstrates that monosymptomatic presentations (isolated cheilitis) are common, with only a minority presenting with the complete triad"", ""reference"": ""PMID:22657098"", ""snippet"": ""Granulomatous cheilitis (Miescher cheilitis)... is the most common monosymptomatic form of the Melkersson-Rosenthal syndrome."", ""supports"": ""SUPPORT""}], ""maximum_value"": 25, ""minimum_value"": 8, ""name"": ""Frequency of Complete Triad"", ""notes"": ""Only 8–25% of MRS cases present with the complete classic triad (recurrent orofacial edema, facial nerve paralysis, fissured tongue). Many patients present with monosymptomatic or oligosymptomatic variants, particularly isolated granulomatous cheilitis, leading to diagnostic delays.\n"", ""unit"": ""percent""}"
6477	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	0	Sex distribution in imaging cohort	Male predominance reported in a cardiothoracic imaging cohort.																																		In a cohort of 38 imaged individuals, 23 were men.																					cases	"{""description"": ""Male predominance reported in a cardiothoracic imaging cohort."", ""name"": ""Sex distribution in imaging cohort"", ""notes"": ""In a cohort of 38 imaged individuals, 23 were men."", ""unit"": ""cases""}"	{}	"{""description"": ""Male predominance reported in a cardiothoracic imaging cohort."", ""evidence"": [{""explanation"": ""This cohort reports a male-predominant sex distribution among imaged individuals."", ""reference"": ""DOI:10.1038/s41598-021-86029-0"", ""snippet"": ""Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging"", ""supports"": ""SUPPORT""}], ""name"": ""Sex distribution in imaging cohort"", ""notes"": ""In a cohort of 38 imaged individuals, 23 were men."", ""unit"": ""cases""}"
6478	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	1	Sex distribution in longitudinal cohort	Male predominance reported in a 64-patient natural history cohort.																																		36 males and 28 females in the cohort.																					cases	"{""description"": ""Male predominance reported in a 64-patient natural history cohort."", ""name"": ""Sex distribution in longitudinal cohort"", ""notes"": ""36 males and 28 females in the cohort."", ""unit"": ""cases""}"	{}	"{""description"": ""Male predominance reported in a 64-patient natural history cohort."", ""evidence"": [{""explanation"": ""The longitudinal cohort reports a modest male predominance."", ""reference"": ""PMID:28661492"", ""snippet"": ""There were 64 patients with Proteus syndrome identified in this study, 28 (43.8%) were female and 36 were male (56.3%)."", ""supports"": ""SUPPORT""}], ""name"": ""Sex distribution in longitudinal cohort"", ""notes"": ""36 males and 28 females in the cohort."", ""unit"": ""cases""}"
6479	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	2	Age in imaging cohort	Average age reported for the cardiothoracic imaging cohort.																												24 years																											years	"{""description"": ""Average age reported for the cardiothoracic imaging cohort."", ""mean_range"": ""24 years"", ""name"": ""Age in imaging cohort"", ""unit"": ""years""}"	{}	"{""description"": ""Average age reported for the cardiothoracic imaging cohort."", ""evidence"": [{""explanation"": ""The imaging cohort reports an average age of 24 years."", ""reference"": ""DOI:10.1038/s41598-021-86029-0"", ""snippet"": ""Of 53 individuals with a confirmed diagnosis of Proteus syndrome at our institution from 10/2001 to 10/2019, 38 individuals (men, n = 23; average age = 24 years) underwent cardiothoracic imaging"", ""supports"": ""SUPPORT""}], ""mean_range"": ""24 years"", ""name"": ""Age in imaging cohort"", ""unit"": ""years""}"
6480	276	Proteus syndrome	Proteus_syndrome.yaml	epidemiology	3	Age at diagnosis	Median age at diagnosis in a natural history cohort.																												19 months																											months	"{""description"": ""Median age at diagnosis in a natural history cohort."", ""mean_range"": ""19 months"", ""name"": ""Age at diagnosis"", ""unit"": ""months""}"	{}	"{""description"": ""Median age at diagnosis in a natural history cohort."", ""evidence"": [{""explanation"": ""The cohort analysis reports a median diagnosis age of 19 months."", ""reference"": ""PMID:28661492"", ""snippet"": ""The median age of diagnosis was 19 months."", ""supports"": ""SUPPORT""}], ""mean_range"": ""19 months"", ""name"": ""Age at diagnosis"", ""unit"": ""months""}"
7027	303	Sengers syndrome	Sengers_syndrome.yaml	epidemiology	0	Limited number of reported long-term survivors	"Published reports note that only a small number of cases have been followed into the second decade, highlighting the rarity of long-term survival data.
"																																		Evidence is based on case-report literature rather than population estimates.																						"{""description"": ""Published reports note that only a small number of cases have been followed into the second decade, highlighting the rarity of long-term survival data.\n"", ""name"": ""Limited number of reported long-term survivors"", ""notes"": ""Evidence is based on case-report literature rather than population estimates.""}"	{}	"{""description"": ""Published reports note that only a small number of cases have been followed into the second decade, highlighting the rarity of long-term survival data.\n"", ""evidence"": [{""explanation"": ""This statement indicates the scarcity of long-term follow-up and limited reported cases."", ""reference"": ""DOI:10.1186/s13052-022-01370-y"", ""snippet"": ""Thus far few reported cases have survived the second decade at their latest examination, and no natural history data are available for the disease."", ""supports"": ""SUPPORT""}], ""name"": ""Limited number of reported long-term survivors"", ""notes"": ""Evidence is based on case-report literature rather than population estimates.""}"
